The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus - PubMed (original) (raw)
The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus
B A Heinz et al. J Virol. 1995 Jul.
Abstract
Enviroxime is an antiviral compound that inhibits the replication of rhinoviruses and enteroviruses. We have explored the mechanism of action of enviroxime by using poliovirus type 1 and human rhinovirus type 14 as model systems. By varying the time of drug addition to virus-infected cells, we determined that enviroxime could be added several hours postinfection without significant loss of inhibition. This suggested that the drug targeted a step involved in RNA replication or protein processing. To identify this target, we mapped 23 independent mutations in mutants that could multiply in the presence of 1 microgram of enviroxime per ml. Each of these mutants contained a single nucleotide substitution that altered one amino acid in the 3A coding region. Using oligonucleotide-directed mutagenesis of cDNA clones, we have confirmed that these single-amino-acid substitutions are sufficient to confer the resistance phenotype. In addition, we conducted two experiments to support the hypothesis that enviroxime inhibits a 3A function. First, we determined by dot blot analysis of RNA from poliovirus-infected cells that enviroxime preferentially inhibits synthesis of the viral plus strand. Second, we demonstrated that enviroxime inhibits the initiation of plus-strand RNA synthesis as measured by the addition of [32P]uridine to 3AB in poliovirus crude replication complexes. To our knowledge, this is the first evidence that 3A can be targeted by antiviral drugs. We anticipate that enviroxime will be a useful tool for investigating the natural function of the 3A protein.
Similar articles
- Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex.
Brown-Augsburger P, Vance LM, Malcolm SK, Hsiung H, Smith DP, Heinz BA. Brown-Augsburger P, et al. Arch Virol. 1999;144(8):1569-85. doi: 10.1007/s007050050611. Arch Virol. 1999. PMID: 10486111 - Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses.
Heinz BA, Vance LM. Heinz BA, et al. J Virol. 1996 Jul;70(7):4854-7. doi: 10.1128/JVI.70.7.4854-4857.1996. J Virol. 1996. PMID: 8676522 Free PMC article. - Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives.
Shimizu H, Agoh M, Agoh Y, Yoshida H, Yoshii K, Yoneyama T, Hagiwara A, Miyamura T. Shimizu H, et al. J Virol. 2000 May;74(9):4146-54. doi: 10.1128/jvi.74.9.4146-4154.2000. J Virol. 2000. PMID: 10756027 Free PMC article. - Rhinovirus Inhibitors: Including a New Target, the Viral RNA.
Real-Hohn A, Blaas D. Real-Hohn A, et al. Viruses. 2021 Sep 7;13(9):1784. doi: 10.3390/v13091784. Viruses. 2021. PMID: 34578365 Free PMC article. Review.
Cited by
- An efficient trans complementation system for in vivo replication of defective poliovirus mutants.
Arita M. Arita M. J Virol. 2024 Jul 23;98(7):e0052324. doi: 10.1128/jvi.00523-24. Epub 2024 Jun 5. J Virol. 2024. PMID: 38837378 Free PMC article. - Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.
Tammaro C, Guida M, Appetecchia F, Biava M, Consalvi S, Poce G. Tammaro C, et al. Pharmaceuticals (Basel). 2023 Jan 29;16(2):203. doi: 10.3390/ph16020203. Pharmaceuticals (Basel). 2023. PMID: 37259352 Free PMC article. Review. - Characterization of Anti-Poliovirus Compounds Isolated from Edible Plants.
Arita M, Fuchino H. Arita M, et al. Viruses. 2023 Mar 31;15(4):903. doi: 10.3390/v15040903. Viruses. 2023. PMID: 37112883 Free PMC article. - Enterovirus A71 antivirals: Past, present, and future.
Wang J, Hu Y, Zheng M. Wang J, et al. Acta Pharm Sin B. 2022 Apr;12(4):1542-1566. doi: 10.1016/j.apsb.2021.08.017. Epub 2021 Aug 20. Acta Pharm Sin B. 2022. PMID: 35847514 Free PMC article. - Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses.
Xia X, Cheng A, Wang M, Ou X, Sun D, Mao S, Huang J, Yang Q, Wu Y, Chen S, Zhang S, Zhu D, Jia R, Liu M, Zhao XX, Gao Q, Tian B. Xia X, et al. Front Immunol. 2022 Jun 2;13:890549. doi: 10.3389/fimmu.2022.890549. eCollection 2022. Front Immunol. 2022. PMID: 35720341 Free PMC article. Review.
References
- Cell. 1982 Feb;28(2):405-12 - PubMed
- Science. 1982 Mar 26;215(4540):1577-85 - PubMed
- Antimicrob Agents Chemother. 1982 Jun;21(6):892-7 - PubMed
- J Virol. 1988 Nov;62(11):4207-15 - PubMed
- J Virol. 1989 May;63(5):2396-9 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources